[Management of hyperuricemia in diabetes].
Hirai
A
A
Second Department of Internal Medicine, Chiba University School of Medicine.
Saito
Y
Y
D000493:Allopurinol / Q000627:therapeutic use; D001553:Benzbromarone / Q000627:therapeutic use; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007333:Insulin Resistance; D011339:Probenecid / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents / Q000627:therapeutic use
D014528:Uricosuric Agents; D014527:Uric Acid; D001553:Benzbromarone; D000493:Allopurinol; D011339:Probenecid